The cancer-associated FGFR4-G388R polymorphism enhances pancreatic insulin secretion and modifies the risk of diabetes.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cell Metabolism

• Publication date

  2013-06-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.cmet.2013.05.002PMID 23747250PMCID PMC4005358
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fundamentals of FGF19 & FGF21 Action In Vitro and In Vivo

  2012cited by this paper
• Hyperinsulinemia enhances c-Myc-mediated mammary tumor development and advances metastatic progression to the lung in a mouse model of type 2 diabetes

  2012cited by this paper
• Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes

  2012cited by this paper
• A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance

  2012cited by this paper
• Phosphorylated Grb14 Is an Endogenous Inhibitor of Retinal Protein Tyrosine Phosphatase 1B, and Light-Dependent Activation of Src Phosphorylates Grb14

  2011cited by this paper
• Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci

  2011cited by this paper
• Effects of a lifestyle intervention in metabolically benign and malign obesity

  2011cited by this paper
• FGFR4 Gly388Arg polymorphism contributes to prostate cancer development and progression: A meta-analysis of 2618 cases and 2305 controls

  2011cited by this paper
• The FGFR4-G388R Polymorphism Promotes Mitochondrial STAT3 Serine Phosphorylation to Facilitate Pituitary Growth Hormone Cell Tumorigenesis

  2011cited by this paper
• FGFR4 transmembrane domain polymorphism and cancer risk: a meta-analysis including 8555 subjects.

  2010cited by this paper
• A single nucleotide change in the mouse genome accelerates breast cancer progression.

  2010influential reference
• Can endogenous hyperinsulinaemia explain the increased risk of cancer development and mortality in type 2 diabetes: evidence from mouse models

  2010cited by this paper
• PI3K(p110&agr;) Protects Against Myocardial Infarction-Induced Heart Failure: Identification of PI3K-Regulated miRNA and mRNA

  2010cited by this paper
• STATs in cancer inflammation and immunity: a leading role for STAT3

  2009cited by this paper
• Association of 18 Confirmed Susceptibility Loci for Type 2 Diabetes With Indices of Insulin Release, Proinsulin Conversion, and Insulin Sensitivity in 5,327 Nondiabetic Finnish Men

  2009cited by this paper
• The Role of Endocrine Insulin-Like Growth Factor-I and Insulin in Breast Cancer

  2008cited by this paper
• FGFR4 Prevents Hyperlipidemia and Insulin Resistance but Underlies High-Fat Diet–Induced Fatty Liver

  2007cited by this paper
• Diabetes mellitus and risk of breast cancer: A meta‐analysis

  2007cited by this paper
• Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women.

  2007cited by this paper
• FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer.

  2006cited by this paper
• Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways.

  2006cited by this paper
• Interaction with Grb14 results in site‐specific regulation of tyrosine phosphorylation of the insulin receptor

  2006cited by this paper
• FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer.

  2006cited by this paper
• FGFR4 GLY388 isotype suppresses motility of MDA-MB-231 breast cancer cells by EDG-2 gene repression.

  2006cited by this paper
• Fibroblast Growth Factor-21 Improves Pancreatic β-Cell Function and Survival by Activation of Extracellular Signal–Regulated Kinase 1/2 and Akt Signaling Pathways

  2006cited by this paper
• FGF-21 as a novel metabolic regulator.

  2005cited by this paper
• Grb10 and Grb14: enigmatic regulators of insulin action--and more?

  2005cited by this paper
• Structural basis for inhibition of the insulin receptor by the adaptor protein Grb14.

  2005cited by this paper
• Regulation and functional roles of Grb14.

  2004cited by this paper
• Hyperinsulinaemia and Increased Risk of Breast Cancer: Findings From the British Women's Heart and Health Study

  2004cited by this paper
• Improved glucose homeostasis and enhanced insulin signalling in Grb14‐deficient mice

  2004influential reference
• The Fibroblast Growth Factor Receptor-4 Arg388 Allele Is Associated with Prostate Cancer Initiation and Progression

  2004cited by this paper
• Involvement of the FGFR4 Arg388 allele in head and neck squamous cell carcinoma

  2004cited by this paper
• Ikaros isoforms in human pituitary tumors: distinct localization, histone acetylation, and activation of the 5' fibroblast growth factor receptor-4 promoter.

  2003cited by this paper
• Expression and misexpression of members of the FGF and TGFβ families of growth factors in the developing mouse pancreas

  2003cited by this paper
• Single nucleotide polymorphism in fibroblast growth factor receptor 4 at codon 388 is associated with prognosis in high‐grade soft tissue sarcoma

  2003cited by this paper
• Inhibition of Insulin Receptor Catalytic Activity by the Molecular Adapter Grb14*

  2002cited by this paper
• Targeted expression of a human pituitary tumor-derived isoform of FGF receptor-4 recapitulates pituitary tumorigenesis.

  2002cited by this paper
• Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

  2002cited by this paper
• Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity.

  2002cited by this paper
• BEYOND CARRIER PROTEINS Sex hormone-binding globulin is synthesized in target cells

  2002cited by this paper
• Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele.

  2002cited by this paper
• The Grb7 family proteins: structure, interactions with other signaling molecules and potential cellular functions

  2001cited by this paper
• Evidence for an interaction between the insulin receptor and Grb7. A role for two of its binding domains, PIR and SH2

  2000cited by this paper
• Attenuation of FGF signalling in mouse beta-cells leads to diabetes.

  2000cited by this paper
• Attenuation of FGF signalling in mouse β-cells leads to diabetes

  2000cited by this paper
• Elevated Cholesterol Metabolism and Bile Acid Synthesis in Mice Lacking Membrane Tyrosine Kinase Receptor FGFR4*

  2000cited by this paper
• Association of Fibroblast Growth Factor Receptor 1 with the Adaptor Protein Grb14

  2000cited by this paper
• Identification of a novel alternative splicing of human FGF receptor 4: soluble-form splice variant expressed in human gastrointestinal epithelial cells.

  2000cited by this paper
• Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4

  2000cited by this paper
• Altered function of insulin receptor substrate-1-deficient mouse islets and cultured beta-cell lines.

  1999cited by this paper
• Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes.

  1999cited by this paper
• Identification of the Rat Adapter Grb14 as an Inhibitor of Insulin Actions*

  1998cited by this paper
• Grb10 Interacts Differentially with the Insulin Receptor, Insulin-like Growth Factor I Receptor, and Epidermal Growth Factor Receptor via the Grb10 Src Homology 2 (SH2) Domain and a Second Novel Domain Located between the Pleckstrin Homology and SH2 Domains*

  1998cited by this paper
• Fibroblast Growth Factor 2 Promotes Pancreatic Epithelial Cell Proliferation Via Functional Fibroblast Growth Factor Receptors During Embryonic Life

  1998cited by this paper
• Differential Expression of the Fibroblast Growth Factor Receptor (FGFR) Multigene Family in Normal Human Adult Tissues

  1997cited by this paper
• Effects of Certain Growth Factors on In Vitro Maturation of Rat Fetal Islet‐like Structures

  1996cited by this paper
• Insulin Receptors in Breast Cancer

  1996cited by this paper
• Signal transduction by fibroblast growth factor receptor-4 (FGFR-4). Comparison with FGFR-1.

  1994cited by this paper
• Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man

  1985cited by this paper

• Association analysis of SOCS3, JAK2 and STAT3 gene polymorphisms and genetic susceptibility to type 2 diabetes mellitus in Chinese population

  2022cites this paper
• Decreased GLUT2 and glucose uptake contribute to insulin secretion defects in MODY3/HNF1A hiPSC-derived mutant β cells

  2021cites this paper
• Type 2 Diabetes, Obesity, and Cancer Share Some Common and Critical Pathways

  2021cites this paper
• A novel hotspot and rare somatic mutation p.A138V, at TP53 is associated with poor survival of pancreatic ductal and periampullary adenocarcinoma patients

  2020cites this paper
• FGFR4 Gly388Arg Polymorphism Affects the Progression of Gastric Cancer by Activating STAT3 Pathway to Induce Epithelial to Mesenchymal Transition

  2020cites this paper
• Identification of type 2 diabetes loci in 433,540 East Asian individuals

  2020cites this paper
• Genome-wide association study of body fat distribution identifies adiposity loci and sex-specific genetic effects

  2019cites this paper
• Identification of type 2 diabetes loci in 433,540 East Asian individuals

  2019cites this paper
• Identification of core genes and pathways in type 2 diabetes mellitus by bioinformatics analysis

  2019cites this paper
• Preclinical Development of U3-1784, a Novel FGFR4 Antibody Against Cancer, and Avoidance of Its On-target Toxicity

  2019cites this paper
• Genome-Wide Association Study of Body Fat Distribution identifies Novel 4 Adiposity Loci and Sex-Specific Genetic Effects

  2018cites this paper
• The Gly385(388)Arg Polymorphism of the FGFR4 Receptor Regulates Hepatic Lipogenesis Under Healthy Diet.

  2018cites this paper
• Genome-wide association study of body fat distribution identifies novel loci and sex-specific effects

  2017cites this paper
• Gender-Specific Association Between FGFR4 Gly388Arg Gene Variants and Hypertension

  2017cites this paper
• FGFR4 polymorphic alleles modulate mitochondrial respiration: A novel target for somatostatin analog action in pituitary tumors

  2016cites this paper
• Genetic insights into the mechanisms of Fgf signaling

  2016cites this paper
• The Fibroblast Growth Factor signaling pathway

  2015cites this paper
• Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy.

  2015cites this paper
• Multifactorial processes to slowing the biological clock: Insights from a comparative approach.

  2015cites this paper
• [Control of insulin signalisation and action by the Grb14 protein].

  2014cites this paper
• Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors

  2014cites this paper
• FGFR4 polymorphic variants modulate phenotypic features of Cushing disease.

  2014cites this paper
• Does a single nucleotide polymorphism in the FGFR explain the connection between diabetes and cancer?

  2013influential citation
• Metabolic Glucose Status and Pituitary Pathology Portend Therapeutic Outcomes in Acromegaly

  2013cites this paper